- Hardware
- Software
- Services
Advanced Visualization Market size was valued at USD 3,214.6 million in 2022 and is poised to grow at a significant CAGR of 11.6% over 2023-2029. Advanced visualization systems are medical devices outfitted with advanced software that efficiently display the various aspects of a living cell. These systems reduce the time it takes clinicians to report results to patients. These systems are widely used in pathological laboratories for various clinical applications. Based on the clinical application, the global advanced visualization market has been segmented into Oncology, Orthopedics, Cardiovascular, Neurology, and Others. The oncology segment is anticipated to grow at a significant CAGR over the forecast years, owing to increased technological advancements in advanced visualization technology and software, rising prevalence of chronic diseases, increasing geriatric population, and the need for efficiency. Early diagnosis and rising awareness of the benefits of advanced visualization tools in disease diagnosis drive the global advanced visualization market. The increasing prevalence of chronic diseases, the rising geriatric population, the need for efficient and early diagnosis, and growing awareness of the benefits offered by advanced visualization tools in disease diagnosis are the factors driving the global advanced visualization market.
Advanced Visualization Market Key Developments:
In October 2020, GE Healthcare launched that its Ultra Edition package for Vivid1 cardiovascular ultrasound systems has received 510k clearance from the US FDA. The system includes new Artificial Intelligence (AI) that enables clinicians to acquire faster, more repeatable exams consistently.
Advanced Visualization Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
11.6%
Largest Market
North-America
Fastest Growing Market
North America
Advanced Visualization Market Dynamics
The growing prevalence of chronic diseases is the primary driver of the global demand for advanced visualization technologies. Due to changes in lifestyle and the scarcity of preventive care, the prevalence of cancer, heart disease, and respiratory diseases is increasing. In 2012, the Centers for Disease Control and Prevention (CDC) estimated that approximately 117 million people in the United States suffer from at least one chronic health condition. Furthermore, the prevalence and mortality rate of various types of cancer rise with age. Moreover, the disease's rapidly increasing burden increases the demand for oncology services in healthcare settings. Due to this, healthcare providers and government organizations are compelled to provide facilities for effectively diagnosing and treating disease, fueling the growth of the advanced visualization market.
North-America got significant share
Advanced Visualization Market Regional Analysis
The Advanced Visualization market in North America will likely hold the highest revenue share in 2021, and the same trend is expected over the forecast period. Increased chronic disease cases and the presence of better healthcare infrastructure Healthcare information systems have enormous potential for lowering costs and improving outcomes. These systems play an important role not only in reducing costs but also in improving diagnostic accuracy. Most hospitals in the United States focus on providing value-based care. Advanced visualization systems are expected to help healthcare providers to do the same. Hence, the market is expected to witness high growth over the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Advanced Visualization Market Segmentation
By Product & Service
By Type of Solution
- Enterprise
- Standalone
By Imaging Modality
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Ultrasound, Nuclear Medicine
- Others
By Clinical Application
- Oncology
- Orthopedics
- Cardiovascular
- Neurology
- Others
Frequently Asked Questions
The Advanced Visualization Market is growing at a CAGR of 11.6% over the next 7 years.
The Asia Pacific is growing at the highest CAGR over 2021- 2028
North America held the highest share in 2021.
AGFA-Gevaert N.V., Medical Systems, Carestream Health, Inc., Fujifilm Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., PRO Medicus Limited, Siemens Healthineers, Terarecon, Inc. are the major companies operating in Advanced Visualization Market.
| 1.Executive Summary |
| 2.Global Advanced Visualization Market Introduction |
| 2.1.Global Advanced Visualization Market - Taxonomy |
| 2.2.Global Advanced Visualization Market - Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Type of Solution |
| 2.2.3. By Imaging Modality |
| 2.2.4. By Clinical Application |
| 2.2.5. By Region |
| 3.Global Advanced Visualization Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Advanced Visualization Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Advanced Visualization Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Hardware |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Software |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Services |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Advanced Visualization Market By Type of Solution, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Enterprise |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Standalone |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Advanced Visualization Market By Imaging Modality, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Magnetic Resonance Imaging (MRI) |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Computed Tomography (CT) |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ultrasound, Nuclear Medicine |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Advanced Visualization Market By Clinical Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Oncology |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Orthopedics |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Cardiovascular |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Neurology |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Others |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.Global Advanced Visualization Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Advanced Visualization Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Hardware |
| 10.1.2.Software |
| 10.1.3.Services |
| 10.2. Type of Solution Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Enterprise |
| 10.2.2.Standalone |
| 10.3. Imaging Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Magnetic Resonance Imaging (MRI) |
| 10.3.2.Computed Tomography (CT) |
| 10.3.3.Ultrasound, Nuclear Medicine |
| 10.3.4.Others |
| 10.4. Clinical Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Oncology |
| 10.4.2.Orthopedics |
| 10.4.3.Cardiovascular |
| 10.4.4.Neurology |
| 10.4.5.Others |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Advanced Visualization Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Hardware |
| 11.1.2.Software |
| 11.1.3.Services |
| 11.2. Type of Solution Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Enterprise |
| 11.2.2.Standalone |
| 11.3. Imaging Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Magnetic Resonance Imaging (MRI) |
| 11.3.2.Computed Tomography (CT) |
| 11.3.3.Ultrasound, Nuclear Medicine |
| 11.3.4.Others |
| 11.4. Clinical Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Oncology |
| 11.4.2.Orthopedics |
| 11.4.3.Cardiovascular |
| 11.4.4.Neurology |
| 11.4.5.Others |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Advanced Visualization Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Hardware |
| 12.1.2.Software |
| 12.1.3.Services |
| 12.2. Type of Solution Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Enterprise |
| 12.2.2.Standalone |
| 12.3. Imaging Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Magnetic Resonance Imaging (MRI) |
| 12.3.2.Computed Tomography (CT) |
| 12.3.3.Ultrasound, Nuclear Medicine |
| 12.3.4.Others |
| 12.4. Clinical Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Oncology |
| 12.4.2.Orthopedics |
| 12.4.3.Cardiovascular |
| 12.4.4.Neurology |
| 12.4.5.Others |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Advanced Visualization Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Hardware |
| 13.1.2.Software |
| 13.1.3.Services |
| 13.2. Type of Solution Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Enterprise |
| 13.2.2.Standalone |
| 13.3. Imaging Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Magnetic Resonance Imaging (MRI) |
| 13.3.2.Computed Tomography (CT) |
| 13.3.3.Ultrasound, Nuclear Medicine |
| 13.3.4.Others |
| 13.4. Clinical Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Oncology |
| 13.4.2.Orthopedics |
| 13.4.3.Cardiovascular |
| 13.4.4.Neurology |
| 13.4.5.Others |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Advanced Visualization Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Hardware |
| 14.1.2.Software |
| 14.1.3.Services |
| 14.2. Type of Solution Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Enterprise |
| 14.2.2.Standalone |
| 14.3. Imaging Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Magnetic Resonance Imaging (MRI) |
| 14.3.2.Computed Tomography (CT) |
| 14.3.3.Ultrasound, Nuclear Medicine |
| 14.3.4.Others |
| 14.4. Clinical Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Oncology |
| 14.4.2.Orthopedics |
| 14.4.3.Cardiovascular |
| 14.4.4.Neurology |
| 14.4.5.Others |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.AGFA-Gevaert N.V. |
| 15.2.2.Medical Systems |
| 15.2.3.Carestream Health, Inc. |
| 15.2.4.Fujifilm Holdings Corporation |
| 15.2.5.GE Healthcare |
| 15.2.6.Koninklijke Philips N.V. |
| 15.2.7.PRO Medicus Limited |
| 15.2.8.Siemens Healthineers |
| 15.2.9.Terarecon, Inc. |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- AGFA-Gevaert N.V.
- Medical Systems
- Carestream Health, Inc.
- Fujifilm Holdings Corporation
- GE Healthcare
- Koninklijke Philips N.V.
- PRO Medicus Limited
- Siemens Healthineers
- Terarecon, Inc.